BridgeMD
New treatment option for Breast Carcinoma
Official title Access to Genetic Testing in Underserved Patients With Cancer
ClinicalTrials.gov ID: NCT06422455
What this study is testing
- What it's testing
- This study compares the experiences of people who receive information about genetic testing from a computer-generated character to patients who receive information from a human genetics healthcare provider. Patients with cancer are increasingly recommended for genetic testing as standard of care.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Age \> 18 years old
- Diagnosed with least one of the following:
- Epithelial ovarian cancer
- Exocrine pancreatic cancer
- Metastatic or high or very high-risk prostate cancer
You likely can't join if
- Patients who cannot provide informed consent
- Patients who cannot see, read, or write
- Patients who have the cancer and clinical characteristics defined in the inclusion criteria, but who do not speak English or Spanish
- Patients with none of the listed cancer diagnoses and clinical characteristics
- Healthcare provider who do not treats cancer patients
See the full eligibility criteria
- Age \> 18 years old
- Diagnosed with least one of the following:
- Epithelial ovarian cancer
- Exocrine pancreatic cancer
- Metastatic or high or very high-risk prostate cancer
- Breast cancer at or before age 50
- Bilateral breast cancer
- Triple negative breast cancer
- Male breast cancer OR
- Healthcare provider who treats patients with any of the above types of cancer
- Able to read and write in English or Spanish
- Able to provide informed consent
- Patients who cannot provide informed consent
- Patients who cannot see, read, or write
- Patients who have the cancer and clinical characteristics defined in the inclusion criteria, but who do not speak English or Spanish
- Patients with none of the listed cancer diagnoses and clinical characteristics
- Healthcare provider who do not treats cancer patients
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
- Rochester, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States; Rochester, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.